Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

How CRISPR and HiBiT can accelerate drug discovery

CRISPR has been called one of the most exciting developments in genetic engineering. It is opening up new possibilities in medicine, particularly for discovering new types of drugs for genetic diseases and new ways of repairing and replacing organs and tissue in regenerative medicine. In an interview with HBI, Philip Hargreaves, Director of Strategic Marketing & Business Development at Promega UK, the UK  branch of US biotech company Promega, spoke about how CRISPR, when combined with Promega’s innovative HiBiT technology, can accelerate the drug discovery process.

Egypt opens door to private sector in healthcare

In May 2024, Egypt approved a law permitting private management of public hospitals, aiming to improve services. While the new law represents a potential opportunity for new investors and international operators, there are a range of factors prospective partners need to consider before entering the Egyptian healthcare market.

Period tracking app Flo reaches unicorn status

London-based Flo Health, a menstrual cycle and ovulation tracking app, has raised over $200 million in a Series C round led by General Atlantic, a New-York based private equity firm. The funding values Flo at over $1 billion, making it the “first purely digital consumer women’s health app to achieve unicorn status”, as well as the first European femtech company to.

Australian private hospital sector in crisis: what is happening and how can it be fixed?

The Australian private hospital sector is in crisis, with approximately 80 hospitals closing in the past five years and another 12 discontinuing maternity or mental health services. Many doctors warn that private maternity services might completely close down within the next five years. The growth in private admissions has fallen significantly short of expectations, primarily due to rising healthcare service costs, increasing out-of-pocket expenses, and unaffordable health insurance.

What innovations are health tech investors most excited about in 2024?

Healthcare is a sector in which it can be hard to innovate. Regulations are tight and risk aversion is rife. This is understandable — justifiable, even — given lives are at stake. But it means the sector doesn’t see much creative destruction in the models it uses for delivering care. 

PMI’s changing business model

Access to primary care is now the number one reason people in the UK want private medical insurance (PMI), according to data collected by UK health insurer Vitality. Other NHS countries have been seeing similar trends since Covid. Katie Tryon, Vitality’s Director of Health Strategy, spoke about how this has completely changed the PMI business model — for the better — at HBI’s conference last month.

What would a Labour government mean for private providers in the UK?

As the UK’s political parties enter the final straight for next Thursday’s general election, the outcome is all but certain, with polling strongly indicating that the Labour Party is set to return to power for the first time since 2010 — at current projections with the largest parliamentary majority in British history.

Find Us